Admescope provides the pharmaceutical, biotechnology and veterinary industry tailor made nonclinical ADME-Tox services. Our service offering covers research services for peptides, biologics and small molecules and is widely spread over the whole ADME-Tox area. The right assays are available, whether in the discovery or lead optimisation phase. The level of data interpretation can be customized according to customer preferences. Currently, Admescope has customers in 29 countries on 4 continents.